Denali Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 16.18 M | $416.12 M | 89.91% | 8.67% |
| BLACKROCK, INC. | 08/07/2026 | 14.03 M | $360.76 M | 7.61% | 7.52% |
| BAILLIE GIFFORD & CO | 08/06/2026 | 11.96 M | $307.62 M | -0.88% | 6.41% |
| STATE STREET CORP | 08/07/2026 | 7.05 M | $181.31 M | 12.39% | 3.78% |
| TEMASEK HOLDINGS (PRIVATE) LTD | 08/07/2026 | 7.01 M | $180.37 M | 0.00% | 3.76% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 6.48 M | $166.59 M | 5.83% | 3.47% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 6.28 M | $161.41 M | 2.08% | 3.36% |
| FMR LLC | 08/13/2026 | 4.54 M | $116.66 M | -0.86% | 2.43% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 4.16 M | $106.89 M | -5.70% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.97 M | $102.21 M | 6.61% | 2.13% |
| HOLOCENE ADVISORS, LP | 08/14/2026 | 3.91 M | $100.44 M | 22.21% | 2.09% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 3.73 M | $96.05 M | 0.07% | 2.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 3.16 M | $81.33 M | -28.66% | 1.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 3.14 M | $80.66 M | 27.27% | 1.68% |
| UBS GROUP AG | 08/13/2026 | 3.12 M | $80.26 M | 21.36% | 1.67% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 2.98 M | $57.31 M | 3.15% | 1.60% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 2.86 M | $73.58 M | 6.26% | 1.53% |
| NORGES BANK | 08/12/2026 | 2.82 M | $72.65 M | 100.00% | 1.51% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 2.79 M | $71.89 M | 9.08% | 1.50% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/12/2026 | 2.57 M | $65.99 M | 2.04% | 1.37% |
| FISHER ASSET MANAGEMENT, LLC | 08/04/2026 | 2.41 M | $62.09 M | -0.93% | 1.29% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 2.21 M | $56.80 M | 1,828.21% | 1.18% |
| CASDIN CAPITAL, LLC | 08/14/2026 | 2.05 M | $52.60 M | 11.14% | 1.10% |
| CRESTLINE MANAGEMENT, LP | 08/14/2026 | 1.91 M | $49.14 M | -13.57% | 1.02% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 1.42 M | $36.52 M | -3.95% | 0.76% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 08/14/2026 | 1.40 M | $35.92 M | 15.44% | 0.75% |
| SIREN, L.L.C. | 08/13/2026 | 1.40 M | $35.92 M | 0.00% | 0.75% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.39 M | $35.74 M | 6.04% | 0.74% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 1.36 M | $34.86 M | 357.17% | 0.73% |
| ABRDN PLC | 07/31/2026 | 1.35 M | $34.61 M | -27.45% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.24 M | $32.02 M | 3.11% | 0.67% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.24 M | $32.02 M | 100.00% | 0.67% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.23 M | $31.66 M | 8.53% | 0.66% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 08/13/2026 | 1.22 M | $31.49 M | 11.35% | 0.66% |
| CANDRIAM S.C.A. | 08/13/2026 | 1.19 M | $30.57 M | 8.19% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 1.13 M | $28.95 M | -10.51% | 0.60% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.03 M | $26.47 M | -45.01% | 0.55% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 991.90 K | $25.51 M | 4.44% | 0.53% |
| MORGAN STANLEY | 08/13/2026 | 961.05 K | $24.72 M | -13.01% | 0.51% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 800.28 K | $20.58 M | 4.20% | 0.43% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 739.01 K | $19.01 M | 132.03% | 0.40% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 712.53 K | $18.33 M | -23.85% | 0.38% |
| CERCANO MANAGEMENT LLC | 08/14/2026 | 625.00 K | $16.08 M | 0.00% | 0.33% |
| NUVEEN, LLC | 08/11/2026 | 608.97 K | $15.66 M | 106.02% | 0.33% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 582.67 K | $14.99 M | 12.98% | 0.31% |
| MARSHALL WACE, LLP | 08/13/2026 | 549.83 K | $14.14 M | -44.53% | 0.29% |
| SEGALL BRYANT & HAMILL, LLC | 08/12/2026 | 519.48 K | $13.36 M | 1.75% | 0.28% |
| CITIGROUP INC | 08/03/2026 | 487.28 K | $12.53 M | 1,140.59% | 0.26% |
| CITADEL ADVISORS LLC | 08/14/2026 | 455.80 K | $11.72 M | 252.51% | 0.24% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 432.80 K | $11.13 M | 100.00% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Denali Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 384 institutional investors and hedge funds held shares of Denali Therapeutics Inc. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 16.18 M
BlackRock, Inc.: 14.03 M
BAILLIE GIFFORD & CO: 11.96 M
STATE STREET CORP: 7.05 M
Temasek Holdings (Private) Ltd: 7.01 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 6.48 M
84.28% of Denali Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 190.38 M shares in the last 24 months. This purchase volume represents approximately $4.06 B in transactions.